BUDS: Benchmark Uncertainty Design Selection for Two-Stage Single-Arm Phase II Trials
The paper introduces BUDS, a framework for selecting two-stage single-arm Phase II trial designs that accounts for historical benchmark uncertainty by optimizing efficiency across a plausible range of outcomes, thereby preventing Type I error inflation while offering explicit trade-offs between robustness and sample size efficiency for both binary and time-to-event endpoints.